Home LiteratureArticle Details
PMID: 21078804 Published · ppublish English Journal Article Randomized Controlled Trial

The role of PET with 13N-ammonia and 18F-FDG in the assessment of myocardial perfusion and metabolism in patients with recent AMI and intracoronary stem cell injection.

Castellani M, Colombo A, Giordano R, Pusineri E, Canzi C, Longari V, Piccaluga E, Palatresi S, Dellavedova L, Soligo D, Rebulla P, Gerundini P

Abstract

Over the last decade, the effects of stem cell therapy on cardiac repair after acute myocardial infarction (AMI) have been investigated with different imaging techniques. We evaluated a new imaging approach using (13)N-ammonia and (18)F-FDG PET for a combined analysis of cardiac perfusion, metabolism, and function in patients treated with intracoronary injection of endothelial progenitors or with conventional therapy for AMI. A total of 15 patients were randomly assigned to 3 groups based on different treatments (group A: bone marrow-derived stem cells; group B: peripheral blood-derived stem cells; group C: standard therapy alone). The number of scarred and viable segments, along with the infarct size and the extent of the viable area, were determined on a 9-segment (13)N-ammonia/(18)F-FDG PET polar map. Myocardial blood flow (MBF) was calculated for each segment on the ammonia polar map, whereas a global evaluation of left ventricular function was obtained by estimating left ventricular ejection fraction (LVEF) and end-diastolic volume, both derived from electrocardiography-gated (18)F-FDG images. Both intragroup and intergroup comparative analyses of the mean values of each parameter were performed at baseline and 3, 6, and 12 mo after AMI. During follow-up, major cardiac events were also registered. A significant decrease (P < 0.05) in the number of scarred segments and infarct size was observed in group A, along with an increase in MBF (P < 0.05) and a mild improvement in cardiac function. Lack of infarct size shrinkage in group B was associated with a marked impairment of MBF (P = 0.01) and cardiac dysfunction. Ambiguous changes in infarct size, MBF, and LVEF were found in group C. No differences in number of viable segments or in extent of viable area were found among the groups. At clinical follow-up, no major cardiac events occurred in group A patients, whereas 2 patients of group B experienced in-stent occlusion and one patient of group C received a transplant for heart failure. Our data suggest that a single nuclear imaging technique accurately analyzes changes in myocardial perfusion and metabolism occurring after stem cell transplantation.

MeSH Terms
Acute Disease Adult Ammonia Coronary Circulation/physiology Endpoint Determination Female Fluorodeoxyglucose F18 Follow-Up Studies Humans Image Interpretation, Computer-Assisted Male Middle Aged Myocardial Infarction/diagnostic imaging,therapy Myocardium/metabolism Nitrogen Radioisotopes Positron-Emission Tomography Radiopharmaceuticals Stem Cell Transplantation/adverse effects Ventricular Function, Left/physiology
Chemicals
Nitrogen Radioisotopes Radiopharmaceuticals Fluorodeoxyglucose F18 Ammonia
Authors & Affiliations
12 authors, click to expand affiliations / ORCID
Castellani Massimo
Department of Nuclear Medicine, Fondazione IRCCS Cà Granda, Milan, Italy. [email protected]
Colombo Alessandro
Giordano Rosaria
Pusineri Enrico
Canzi Cristina
Longari Virgilio
Piccaluga Emanuela
Palatresi Simone
Dellavedova Luca
Soligo Davide
Rebulla Paolo
Gerundini Paolo
Article Info
Journal
Journal of nuclear medicine : official publication, Society of Nuclear Medicine
Abbr.
J Nucl Med
ISSN
1535-5667
Published
2010-12-00
Epub
2010-00-15
Pages
1908-16
Language
English
Region
United States
NLM ID
0217410
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]